The Evolution of Preimplantation Genetic Screening
Advances in next generation sequencing technology are providing clinicians with powerful tools to screen embryos for developmental disorders and answer many key questions about human fertility. Why do some embryos fail to develop? What are the different genetics at play? How can we ensure that an embryo will develop into a health child?
You can also find out more about Illumina’s preimplantation genetic screening work here.
What will the webcast cover?
This presentation will introduce the background to infertility in the US, the benefits of PGS, how PGS works, and how next generation sequencing techniques can be used to develop and improve PGS.
- Background on infertility
- Benefits of Preimplantation Genetic Screening (PGS)
- Embryo selection methods
- Next generation sequencing in PGS
- Initial results of PGS by NGS
Who is the speaker?
Kumar Duraiswamy, MD, MBA
Associate Director, Clinical – Reproductive and Genetic Health, Illumina
Dr Duraiswamy has over 14 years of medical in vitro diagnostic experience, and is formerly one of two medical directors at Siemens Healthcare Diagnostics. Since joining Illumina Kumar has been helping to educate the clinical community about the benefits of preimplantation genetic screening.
How do I watch?
To watch the broadcast simply enter your registration details below. You will be automatically redirected to the webcast page.
If you have any problems accessing this content please get in touch with firstname.lastname@example.org.